EVERSANA, a pioneer of next-generation commercial services to the global life sciences industry, today announced that its agency team at EVERSANA INTOUCH has been named a multi-category winner in the 2023 PM360 Pharma Choice Awards.
The team earned two gold awards in the App and the Philanthropic categories respectively for work with The Chrysalis Initiative’s “Erase the Line” campaign. Additionally, EVERSANA INTOUCH was named a silver award winner in the Self-Promotion/Corporate Campaign category for its NEXTMAKERS campaign.
“We take great pride in knowing that our work is respected by PM360 and by peers throughout the industry,” said Jim Lang, CEO at EVERSANA. “These accolades reinforce the power of delivering world-class, impactful campaigns that help to improve healthcare worldwide.”
Since 2009, the PM360 Pharma Choice awards have served as the only industry awards to recognize outstanding achievement and creativity in healthcare and life sciences marketing by allowing the industry to choose the winners. All submissions are placed online where anyone in the industry can vote for their favorites based on content, format, imagination, influence on the industry, impact on the audience, and overall quality. This year, more than 8,500 votes were cast to decide the winners.
In addition to the three winners in each category, the top four overall vote-getters receive special recognition by gracing PM360’s January/February 2023 issue cover. This year, The Chrysalis Initiative for “Erase the Line” in the App category was included among the top honors.
Erase the Line is a first-of-its-kind digital platform for, and by, African American women fighting breast cancer – who are 40% more likely to die from the disease than their white counterparts in the United States, due to disparities of care.
In total, 42 winners across 14 distinct categories are featured in the February issue of PM360 Magazine.
EVERSANA® is a leading provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 500 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com or connect through LinkedIn and Twitter.
About EVERSANA INTOUCH
EVERSANA INTOUCH is a global, full-service marketing agency network serving the life sciences industry, and is the first – and only – agency network to be part of a fully integrated commercialization platform through EVERSANA®. EVERSANA INTOUCH provides marketing services – connected and powered by data-rich, digitally forward analytics – through its affiliates: EVERSANA INTOUCH Solutions, EVERSANA INTOUCH Proto, EVERSANA INTOUCH Seven, EVERSANA INTOUCH Oxygen, EVERSANA INTOUCH Engage, EVERSANA INTOUCH B2D, EVERSANA INTOUCH Media, and EVERSANA INTOUCH International. To learn more, visit eversanaintouch.com or connect through Facebook, LinkedIn, Twitter, or Instagram.